Shares of Sun Pharmaceutical Industries slipped 4 per cent to Rs 851.50 on the BSE in Tuesday’s trade, falling 6 per cent since yesterday when the company posted a net loss of Rs 2,277 crore for the fourth quarter of the financial year 2021-22 (Q4FY22).
The loss came on account of settlement charges of pending litigations in the US, and restructuring operations in some countries. Adjusted profit grew 18 per cent year on year (YoY) to Rs 1,582 crore.
Consolidated sales from operations rose 11 per cent YoY at Rs 9,386 crore over Q4 last year. Earnings before